WP760, a melanoma selective drug Mingzhong ZhengWaldemar PriebeElizabeth A. Grimm Original Article 29 December 2006 Pages: 625 - 633
Novel paclitaxel formulations for oral application: a phase I pharmacokinetic study in patients with solid tumours S. A. VeltkampH. RosingJ. H. M. Schellens Original Article 05 January 2007 Pages: 635 - 642
Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model Sarah BremBetty TylerHenry Brem Original Article 26 January 2007 Pages: 643 - 650
Short hairpin RNAs targeting Bcl-xL modulate senescence and apoptosis following SN-38 and irinotecan exposure in a colon cancer model S. M. GuichardM. L. HuaD. I. Jodrell Original Article 02 February 2007 Pages: 651 - 660
Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancer Jeffrey A. MeyerhardtJeffrey W. ClarkCharles S. Fuchs Original Article 11 January 2007 Pages: 661 - 670
Comparison between sonodynamic effect with protoporphyrin IX and hematoporphyrin on sarcoma 180 QuanHong LiuXiaoBing WangQiao Hao Original Article 12 January 2007 Pages: 671 - 680
Vaticanol C, a novel resveratrol tetramer, reduces lymph node and lung metastases of mouse mammary carcinoma carrying p53 mutation Masa-Aki ShibataYukihiro AkaoYoshinori Otsuki Original Article 26 January 2007 Pages: 681 - 691
Effect of gastrectomy on the pharmacokinetics of S-1, an oral fluoropyrimidine, in resectable gastric cancer patients Mitsugu KochiMasashi FujiiTadatoshi Takayama Original Article Open access 15 February 2007 Pages: 693 - 701
Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell lines Jia WeiBaorui LiuLixia Yu Original Article 26 January 2007 Pages: 703 - 711
Role of NADPH cytochrome P450 reductase in activation of RH1 Asher BegleiterMarsha K. LeithBrian B. Hasinoff Original Article 26 January 2007 Pages: 713 - 723
Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study Joaquín CasalMargarita AmenedoJosé L. Tisaire Original Article 02 February 2007 Pages: 725 - 732
Weekday on-weekend off oral capecitabine: a phase I study of a continuous schedule better simulating protracted fluoropyrimidine therapy G. PentheroudakisP. PappasN. Pavlidis Original Article 28 February 2007 Pages: 733 - 739
Tetrandrine achieved plasma concentrations capable of reversing MDR in vitro and had no apparent effect on doxorubicin pharmacokinetics in mice Chun-Ling DaiHui-Yu XiongLi-Wu Fu Original Article 02 February 2007 Pages: 741 - 750
The inhibition of glutamine synthetase sensitizes human sarcoma cells to l-asparaginase S. TarditoJ. UggeriO. Bussolati Original Article 26 January 2007 Pages: 751 - 758
Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane®) on three treatment schedules in patients with solid tumors Thomas E. StinchcombeMark A. SocinskiE. Claire Dees Original Article 07 February 2007 Pages: 759 - 766